United States · FDA National Drug Code directory

Cetirizine HCl

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
72657-130_42c1f2da-97b4-4583-bf62-368be53900c2
Product NDC
72657-130
Form
KIT
Composition / generic term
Cetirizine
Labeler
GLENMARK THERAPEUTICS INC., USA
Marketing category
ANDA
Marketing start / end (source format)
20240513
Source listing expiry
20271231

Source-listed ingredients

Separate ingredient quantities are not available in this snapshot. Any composition term above is preserved as source text.

These values do not establish equivalence or a dose recommendation.

Packages

  • 1 KIT in 1 PACKAGE (72657-130-05) * 1 BOTTLE in 1 CARTON / 60 TABLET in 1 BOTTLE * 1 BOTTLE in 1 CARTON / 90 TABLET in 1 BOTTLE · 72657-130-05

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →